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The technological achievements of  modern molecular 
biology are providing ever-increasing insight into the 
regulation of protein expression and the structure and 
function of  proteins. The production of  recombinant 
proteins has had a major impact in biology and medicine. 
The reviews published in this year's issue of  Current Opin- 
ion in Biotechnology summarize significant breakthroughs 
in the ability to engineer the host organism to optimize 
production of  specific polypeptides. These technological 
advances are being applied to an ever-increasing nmnber 
of important biological questions and are providing im- 
proved methods to diagnose and treat disease. 
Microbial systems are most commonly used for the pro- 
duction of  foreign proteins. This issue contains two 
reviews on the secretion of  heterologous proteins in 
microbial systems. Expression of  proteins secreted into 
the periplasmic space or into the conditioned medium 
of  Escherichia coli can be achieved at a high level to yield 
properly folded and functional proteins. Blight, Cher- 
vaux and Holland (pp 468-474) review approaches for 
optimizing protein secretion in E. coil The advantages 
and disadvantages of  directing protein expression into the 
periplasmic space or into the external medium are dis- 
cussed. With a better understanding of the mechanism 
of  SecAY-dependent protein export into the periplas- 
mic space and a greater appreciation of  the role of  
protein folding in protein export, it will be possible 
to manipulate E. coli genetically to improve the yield 
of proteins exported into the periplasmic space. Re-  
cently, E. coli has been engineered to utilize targeting 
and secretion signals derived from pathogenic strains 
with little loss in efficiency. Blight et al. discuss the 
use and efficiency of different systems to direct trans- 
location across the inner and outer E. coli membrane. 
Future developments are likely to manipulate cellu- 
lar machinery to improve protein folding and levels of  
specific membrane translocators. Brawner (pp 475-481) 
reviews recent advances in heterologous gene expression 
in Streptomyces, a group of Gram-positive bacteria fie- 
quently used in fermentation to produce antibiotics. 
Analysis of soluble CD4 expression in Streptomyces livi- 
dans has indicated that transcription initiation, signal 
peptide cleavage, and protein degradation are the key 
factors to achieve high-level expression. Brawner reviews 
advances in our understanding concerning each of  these 
processes, which can now be utilized to engineer Strep- 
tomyces for high-level expression of  heterologous genes. 
The next two reviews summarize approaches to dis- 
sect protein-protein interactions. Mendelsohn and Brent 
(pp 482-486) review the yeast two-hybrid system, which 
can be used to isolate genes encoding interacting proteins 
and to characterize protein-protein interactions. The ad- 
vantages and disadvantages of  the different systems cur- 
rently available are discussed. This rapidly evolving tech- 
nology provides a sensitive method to measure protein 
interactions. Schatz (,pp 487-494) describes recent ad- 
vances in the technology to construct and screen peptide 
libraries using biological systems, comparing them with 
chemically synthesized combinatorial libraries. New re- 
ceptor ligands and substrates for peptide-modifying en- 
zymes have been isolated using these approaches and will 
facilitate the development of  diagnostics and treatments 
for human disease. 
The efficiency of nucleic acid incorporation into the 
cell is a crucial factor in determining the utility of  a 
particular method for introducing genetic material into 
cells. This issue contains several reviews on the different 
vehicles employed for introducing genetic material into 
mammalian cells to obtain protein expression. Liljestr6m 
(pp 495-500) describes the advantages and disadvantages 
of  alphavirus RNA expression vectors based on Semliki 
Forest virus and Sindbis virus. The ability to trans- 
fect R N A  into the cytoplasm and to obtain efficient 
replication and translation has provided a versatile tool 
for heterologous gene expression. Recent developments 
and successes are described. The development of  a con- 
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vectors more versatile and amenable to many investiga- 
tors. Ulaeto and Hruby (pp 501-504) discuss the use of 
recombinant vaccinia viruses as vaccines. The smallpox 
vaccination program demonstrated the ability ofvaccinia 
virus to elicit long-lasting immunity. Vaccinia has been 
engineered to deliver specific antigens to elicit immune 
responses and protective immunity in animals. Even so, 
widespread use of  recombinant vaccinia vaccines will be 
limited until a better understanding of the immune re- 
sponse to vaccinia infection is obtained. Over the past 
year, it was demonstrated that immunity induced by a 
recombinant vaccinia virus can be boosted by secondary 
immunization with purified protein. Vaccinia virus can 
both induce immunity to pathogens that have very dif- 
ferent life cycles and/or routes of  infection and be used 
to define immunodominant antigens. Presently, studies 
are elucidating the interaction of  the virus with the 
immune system. The potential of  vaccinia virus as a 
vaccine will be realized only after we have achieved a 
greater understanding of how the virus interacts with 
the immune system. Montgomery et al. (pp 505-510) 
describe both the advantages and successful application 
of  injection of non-replicating DNA expression vec- 
tors into cells in viuo. This approach provides a new 
vaccine technology to generate immune responses in 
animal models, with the ultimate goal of developing vac- 
cines for humans, and it has also been applied as an anti- 
tumor therapy. Different methods are described that uti- 
lize either naked DNA or complexed DNA, which enter 
the cell by different mechanisms. 
Frequently, it is desirable to regulate the expression of 
a particular gene product. Two approaches described in 
this issue have proven successful. In the first approach, 
reviewed by Picard (pp 511-515), chimeric proteins are 
constructed in which the activity of  the protein can be 
activated by addition of  an inducer. For example, one 
novel approach recently described is the induction of 
dimerization by fusion to the FKS06-binding protein 
and addition of a dimeric derivative of FK506. Al- 
ternatively, numerous examples have now been found 
where the function of  proteins fused to a steroid hor- 
mone binding domain can be activated by addition of  the 
appropriate steroid. The second approach, which uses an 
inducible expression system, is described by Gossen et al. 
(pp 516--520). To date, the best success for high-level in- 
duction and expression has been derived using bacterial 
regulatory elements that are engineered into mammalian 
cells. Gossen et al. describe the advantages and disadvan- 
tages of  the lactose and tetracycline repressor/operator 
systems. These repressors have been modified by fusion 
to the herpes simplex virus transcriptional transactivator 
domain of  VP16. These systems have also been adapted 
to obtain inducible expression in transgenic animals. 
Insight into gene function has been greatly facili- 
tated by the ability to genetically modify the murine 
genome in specifically designed ways. The use of  spe- 
cific DNA recombination systems from bacteriophage 
lambda ( C r e /  loxP) or Saccharomyces cerevisiase (FLP/FlLT) 
has dramatically enhanced our power to manipulate large 
DNA molecules in vivo and in vitro. It is possible to 
regulate specific recombination events either to turn 
genes 'on' or 'off'  or to generate chromosomal dele- 
tions/inversions. Sauer (pp 521-527) has pioneered this 
technology and reviews recent developments and appli- 
cations. It is now possible to create new alleles to study 
diverse biological problems, lLecent advances in the abil- 
ity to engineer the germline of  mice are discussed by 
P, amirez-Solis and Bradley (pp 528-533). The ability 
to perform 'hit and run' or 'double replacement', the 
use of  specific recombinases to generate tissue-specific 
or temporal-specific genetic alterations, and the ability 
to transfer large pieces of  DNA (up to 600 kb) into the 
germline all represent significant advances. 
The level of  protein synthesis and secretion from a host 
cell is dependent upon the rate ofpolypeptide chain ini- 
tiation and elongation as well as the rate of  protein fold- 
ing and transport through the secretory apparatus. This 
issue contains several reviews concerning the regulation 
of  polypeptide chain synthesis, the rate of polypeptide 
folding, and the cellular response to unfolded protein 
within the secretory pathway. In the final review in this 
issue (pp 550-557), I describe the factors that regulate 
translation initiation in eukaryotic cells. Recently, it has 
become apparent that the control of  polypeptide chain 
initiation is coupled to cell growth. In fact, several genes 
have now been identified that control translation initia- 
tion and that act either as proto-oncogenes or tumor- 
suppressor genes. It is important to understand how 
proteins fold in vivo and the role that protein chaperones 
and foldases play. Gilbert (pp 534-539) reviews the role 
of protein chaperones in protein folding in vitro and in 
vivo. Individual proteins may require a specific sequence 
of defined interaction with multiple chaperones in vivo. 
Although it may be possible to employ effective methods 
to improve protein folding in vivo, the approaches rely 
largely on trial and error. As protein expression levels in- 
crease, a greater amount of protein aggregation occurs in 
the endoplasmic reticulum (ER). The presence of these 
unfolded proteins induces a cellular response to induce a 
set of  genes that encode protein chaperones. Alterations 
in'protein chaperone expression can affect protein ag- 
gregation and influence rates of  secretion. McMillan et 
al. (pp 540-545) summarize present knowledge con- 
cerning the signal-transduction pathway in response to 
unfolded protein in the EIL that results in the induc- 
tion of  transcription of chaperone-encoding genes in the 
nucleus. 
The majority of  therapeutically relevant proteins derived 
from recombinant DNA technology contain significant 
amounts of carbohydrate. Oligosaccharide structures can 
dramatically affect many properties of  proteins. In gen- 
eral, polypeptides contain a variety of  oligosaccharide 
structures that can alter protein functions, such as plasma 
half-life, receptor affinity, or immunogenicity. Recently, 
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it has become appreciated that cell-culture conditions 
can significantly affect oligosaccharide structure of  re- 
combinant proteins in many different ways. In their 
review, Andersen and Goochee (pp 546-549) summa- 
rize what is presently known about how different cell- 
culture conditions can influence both asparagine- and 
serine/threonine-linked glycosylation. An understand- 
ing of the cell-culture variables that affect glycosylation 
will enable the carbohydrate structure/content of a pro- 
tein to be optimized for biological activity and improve 
consistency in the production of  recombinant proteins. 
Since the original conception of  this issue on expression 
systems in 1990, major improvements have been made 
in our ability to engineer host cells for the produc- 
tion of  specific proteins. Technological developments 
have led the way to an explosion of  information on 
the mechanisms that control m R N A  production, pro- 
tein synthesis and folding, and secretion. As a conse- 
quence, the way is opening for further developments 
and applications of  expression technologies. Thus, in 
the future, it will be possible to specifically design the 
host cell to optimize protein production. In addition, 
novel approaches to obtain more efficient transfer of ge- 
netic material into host cells will certainly have impact 
on human gene therapy. Strategies to obtain tissue-spe- 
cific and inducible expression in transgenic animal mod- 
els will have tremendous impact on our understanding of  
cell biology and development. More importantly, these 
technological improvements are, even now, being trans- 
lated into methods to study protein-protein interactions 
toward the development of  specific approaches to inter- 
vene in human disease. It will be interesting to see what 
unexpected developments the next five years will hold. 
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